medigraphic.com
ISSN 2007-8560 (Print)
Órgano Oficial de Difusión Científica de la Federación Mexicana de Colegios de Ortopedia y Traumatología, A.C. (FEMECOT)

2012, Number 4

<< Back Next >>

Ortho-tips 2012; 8 (4)

Cuidado del paciente geriátrico tratado con anticoagulantes orales

Saldaña MEA

Language: Spanish
References: 18
Page: 249-257
PDF size: 59.32 Kb.


ABSTRACT

In Mexico, our rate of aging is increasing. Our population pyramid in the coming years will be higher in the age of over 60 years. The worrisome cardiovascular risk factors such as smoking, hypertension, diabetes, physical inactivity, obesity, and dyslipidemia who causing thromboembolic diseases in this group of patients are increasing and that it is necessary to anticoagulant therapy because of the risks of recurrent thromboembolic events, or prophylaxis after elective surgery of hip or knee replacement. Therefore, to treat our patients with these therapies must take extra care, since the appropriate dosage, to have in mind that a simple vaccine can alter the coagulation cascade, even when the patient is anticoagulated. Therefore, due to the above reasons, it is necessary to write this article, to remind us that we should do to take care to our patients and at the moment of discharge from the hospital and/or when they leave the office with anticoagulant therapy.


REFERENCES

  1. Organización de las Naciones Unidas. Segunda Asamblea Mundial Sobre el Envejecimiento. Madrid; 2002. Disponible en: http://www.un.org/spanish/envejecimiento/index.html

  2. United Nations. Department of Economic and Social Affairs, Population Division. World Population Ageing 1950-2050. New York: UN; 2002. Available: http://www.un.org/esa/population/publications/worldageing19502050/

  3. Zúñiga E, Vega D. Envejecimiento de la población de México. Reto del siglo XXI. México: Consejo Nacional de Población; 2004. Disponible en: http://www.marista.edu.mx/documents/download/34/envejecimiento-de-la-poblacion-en-mexico

  4. Castro V, Gómez-Dantés H, Negrete-Sánchez J, Tapia-Conyer R. Las enfermedades crónicas en las personas de 60-69 años. Salud Pública Mex 1996; 38: 438-447.

  5. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P et al. Encuesta Nacional de Salud. 2000. Tomo 2. La salud de los adultos. Cuernavaca: Instituto Nacional de Salud Pública; 2003.

  6. International Diabetes Federation. Worldwide definition of the metabolic syndrome [Access: July 23, 2007]. Available in: http://www.idf.org/webdata/docs/IDF_Meta_def_fi nal.pdf. 7

  7. Shamah-Levy T, Cuevas-Nasu L, Mundo-Rosas V, Morales-Ruán C, Cervantes-Turrubiates L, Villalpando-Hernández S. Estado de salud y nutrición de los adultos mayores en México: resultados de una encuesta probabilística nacional. Salud Pública Mex [revista en línea] 2008; 50(5). Disponible: http://redalyc.uaemex.mx/src/inicio/IndArtRev.jsp?iCveNumRev=10411&iCveEntRev=106

  8. Karwinski B, Svendsen E. Comparison of clinical and post mortem diagnosis of pulmonary embolism. J Clin Pathol 1989; 42: 135-139.

  9. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989; 82: 203-205.

  10. Coventry MB, Nolan DR, Beckenbaugh RD. A delayed prophylactic anticoagulation: a study of results and complications in 2,012 total hip arthroplasties. J Bone Joint Surg Am 1973; 55: 1487-1492.

  11. Salzrnan EW, Hirsh J. Prevention of venous thromboembolism. In: Colman RW, Hirsh J, warder VJ, Salzman EW, eds. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia, PA: JB Lippincott; 1982: 986-999.

  12. Reis SE, Hirsch DR, Wilson MG, Donovan BC, Goldhaber SZ. Program for the prevention of venous thromboembolism in high-risk orthopaedic patients. J Arthroplasty 1991; 6 (Suppl): 11-16.

  13. Francis CW, Pellegrini VD Jr, Marder VJ, Harris CM, Totterman S, Gabriel KR, et al. Prevention of venous thrombosis after total hip arthroplasty. Antithrombin 111 and low-dose heparin compared with dextran 40. J Bone Joint Surg Am 1989; 71: 327-335.

  14. Collins R, Srimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic and urologic surgery. N Engl J Med 1988; 318: 1162-1173.

  15. Martínez RA. Fracturas de cadera en ancianos. Pronóstico, epidemiología. Aspectos generales. Experiencia. Rev Colombiana de Ortopedia y Traumatología 2005; 19(1): 20-28.

  16. Francis CW, Pellegrini VD Jr, Harris CM, Marder VJ. Antithrombin 111 prophylaxis of venous thromboembolic disease after total hip or total knee replacement. Am J Med 1989; 87: 6615-6517.

  17. Modelo de evaluación GENESIS-SEFH. Govern de les Illes Balears. Servei de Salut. Versión no. 3.0. Septiembre, 2009.

  18. Clínica Universidad de Navarra [sede web]. Navarra: Morales de Alava I; última revisión: jueves, 6 octubre 2011. Consejos para el paciente anticoagulado. Disponible en: http://www.cun.es/area-salud/salud/consejos-salud/consejos-paciente-anticoagulado




2020     |     www.medigraphic.com